ABSTRACT
Altered metabolism has been implicated in the pathogenesis of inflammatory diseases. NADPH oxidase 4 (NOX4), a source of cellular superoxide anions, has multiple biological functions that may be of importance in inflammation and in the pathogenesis of human metabolic diseases, including diabetes. However, the mechanisms by which NOX4-dependent metabolic regulation affect the innate immune response remain unclear. Here we show that deficiency of NOX4 resulted in reduced expression of carnitine palmitoyltransferase 1A (CPT1A), which is a key mitochondrial enzyme in the fatty acid oxidation (FAO) pathway. The reduced FAO resulted in less activation of the nucleotide-binding domain, leucine-rich-repeat-containing receptor (NLR), pyrin-domain-containing 3 (NLRP3) inflammasome in human and mouse macrophages. In contrast, NOX4 deficiency did not inhibit the activation of the NLR family, CARD-domain-containing 4 (NLRC4), the NLRP1 or the absent in melanoma 2 (AIM2) inflammasomes. We also found that inhibition of FAO by etomoxir treatment suppressed NLRP3 inflammasome activation. Furthermore, Nox4-deficient mice showed substantial reduction in caspase-1 activation and in interleukin (IL)-1ß and IL-18 production, and there was improved survival in a mouse model of NLRP3-mediated Streptococcus pneumoniae infection. The pharmacologic inhibition of NOX4 by either GKT137831, which is currently in phase 2 clinical trials, or VAS-2870 attenuated NLRP3 inflammasome activation. Our results suggest that NOX4-mediated FAO promotes NLRP3 inflammasome activation.
Subject(s)
Fatty Acids/metabolism , Lipid Metabolism/immunology , Macrophages/immunology , NADPH Oxidases/genetics , NLR Family, Pyrin Domain-Containing 3 Protein/immunology , Adaptor Proteins, Signal Transducing/immunology , Adaptor Proteins, Signal Transducing/metabolism , Animals , Apoptosis Regulatory Proteins/immunology , Apoptosis Regulatory Proteins/metabolism , Benzoxazoles/pharmacology , Calcium-Binding Proteins/immunology , Calcium-Binding Proteins/metabolism , Carnitine O-Palmitoyltransferase/genetics , Carnitine O-Palmitoyltransferase/metabolism , Cytokines/immunology , DNA-Binding Proteins/immunology , DNA-Binding Proteins/metabolism , Humans , Immunoblotting , Inflammasomes/immunology , Lipid Metabolism/drug effects , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/metabolism , Metabolomics , Mice , Mice, Knockout , NADPH Oxidase 4 , NADPH Oxidases/antagonists & inhibitors , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Oxidation-Reduction , Pyrazoles/pharmacology , Pyrazolones , Pyridines/pharmacology , Pyridones , Real-Time Polymerase Chain Reaction , Streptococcal Infections/immunology , Streptococcus pneumoniae , Triazoles/pharmacologyABSTRACT
Chronic obstructive pulmonary disease (COPD) is linked to both cigarette smoking and genetic determinants. We have previously identified iron-responsive element-binding protein 2 (IRP2) as an important COPD susceptibility gene and have shown that IRP2 protein is increased in the lungs of individuals with COPD. Here we demonstrate that mice deficient in Irp2 were protected from cigarette smoke (CS)-induced experimental COPD. By integrating RNA immunoprecipitation followed by sequencing (RIP-seq), RNA sequencing (RNA-seq), and gene expression and functional enrichment clustering analysis, we identified Irp2 as a regulator of mitochondrial function in the lungs of mice. Irp2 increased mitochondrial iron loading and levels of cytochrome c oxidase (COX), which led to mitochondrial dysfunction and subsequent experimental COPD. Frataxin-deficient mice, which had higher mitochondrial iron loading, showed impaired airway mucociliary clearance (MCC) and higher pulmonary inflammation at baseline, whereas mice deficient in the synthesis of cytochrome c oxidase, which have reduced COX, were protected from CS-induced pulmonary inflammation and impairment of MCC. Mice treated with a mitochondrial iron chelator or mice fed a low-iron diet were protected from CS-induced COPD. Mitochondrial iron chelation also alleviated CS-induced impairment of MCC, CS-induced pulmonary inflammation and CS-associated lung injury in mice with established COPD, suggesting a critical functional role and potential therapeutic intervention for the mitochondrial-iron axis in COPD.
Subject(s)
Bronchitis/genetics , Iron Chelating Agents/pharmacology , Iron-Binding Proteins/genetics , Iron/metabolism , Lung/metabolism , Mitochondria/metabolism , Nicotiana , Pulmonary Disease, Chronic Obstructive/genetics , Pulmonary Emphysema/genetics , Smoke/adverse effects , Aged , Aged, 80 and over , Airway Remodeling , Animals , Bronchitis/etiology , Disease Models, Animal , Electron Transport Complex IV/metabolism , Electrophoretic Mobility Shift Assay , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Gene Expression Profiling , Humans , Immunoblotting , Immunohistochemistry , Immunoprecipitation , Iron Regulatory Protein 2/genetics , Iron Regulatory Protein 2/metabolism , Iron, Dietary , Lung/drug effects , Lung Injury/etiology , Lung Injury/genetics , Membrane Potential, Mitochondrial , Mice , Mice, Knockout , Microscopy, Confocal , Microscopy, Electron, Transmission , Microscopy, Fluorescence , Mitochondria/drug effects , Mucociliary Clearance/genetics , Pneumonia/etiology , Pneumonia/genetics , Pulmonary Disease, Chronic Obstructive/etiology , Pulmonary Disease, Chronic Obstructive/metabolism , Pulmonary Emphysema/etiology , Real-Time Polymerase Chain Reaction , Smoking/adverse effects , FrataxinABSTRACT
Cellular metabolism can impact cell life or death outcomes. While metabolic dysfunction has been linked to cell death, the mechanisms by which metabolic dysfunction regulates the cell death mode called necroptosis remain unclear. Our study demonstrates that mitochondrial oxidative phosphorylation (OXPHOS) activates programmed necrotic cell death (necroptosis) in human lung epithelial cells. Inhibition of mitochondrial respiration and ATP synthesis induced the phosphorylation of mixed lineage kinase domain-like protein (MLKL) and necroptotic cell death. Furthermore, we demonstrate that the activation of AMP-activated protein kinase (AMPK), resulting from impaired mitochondrial OXPHOS, regulates necroptotic cell death. These results suggest that impaired mitochondrial OXPHOS contributes to necroptosis in human lung epithelial cells.
